MHRA’s Lee To Give UK Medtech Industry Greater Diagnostics Focus
Executive Summary
The UK ABHI has created a new role for a director of diagnostics regulation, which MHRA IVD’s policy adviser Steve Lee will fill later this month.
You may also be interested in...
Interview: ‘More Forward Thinking’ Needed For UK IVD Industry As Brexit Looms
Incoming head of diagnostic regulation at the UK ABHI Steve Lee makes a plea for more detailed MHRA guidance around product registration requirements for the post-EU national market.
Cancer Research UK: Early Diagnosis And Disease Detection Must Not Be Eclipsed By COVID-19
Coronavirus has diverted the focus of health systems away from early cancer detection, says a new report by Cancer Research UK, urging a rebalancing of priorities.
UK Medtech Industry Targets A National Diagnostics Strategy
NHS England’s Long Term Plan puts much emphasis on better use of diagnostic tools in health-care delivery. The UK medtech industry is now pressing for a strategy to ensure that these technologies are factored into all patient pathways. It says the data derived will be used to improve patient outcomes and system efficiency.